Shares Of Aurobindo Pharma Added 2 Percent As Company Received USFDA - Dollar Advisory & Financial Services

Breaking

Tuesday, 26 June 2018

Home Equity Tips Today Live share tips Online Equity Tips option trading tips Sensex Tips share market tips STBT trading tips stock market news today equity tips Shares Of Aurobindo Pharma Added 2 Percent As Company Received USFDA

Shares Of Aurobindo Pharma Added 2 Percent As Company Received USFDA

Shares of Aurobindo Pharma added 2 percent as company received USFDA approval for Ertapenem injection.

The company has received final approval from the USFDA to manufacture and market Ertapenem injection 1 g/vial. Ertapenem injection is a generic equivalent of Merck Sharp & Dohme Corp’s Invanz injection. The product will be launched in July 2018.

Ertapenem injection is used for the treatment of moderate to severe infections caused by susceptible bacteria. Also indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery.

For more information ✆ +91 9111-179961 or Visit Dollar Advisory
Tags
Share This
Posted by at
Labels: , , , , , , , ,

1 comment:

  1. Dariya18 August 2020 at 15:34

    Hey...Great information thanks for sharing such a valuable information. you may also check our blog.
    Shares of Aurobindo Pharma
    Aurobindo Pharma Limited

    ReplyDelete

Subscribe to: Post Comments (Atom)